{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:41Z","timestamp":1787067341030,"version":"build-2736575974"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,12]]},"DOI":"10.1093\/pch\/pxx179","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T11:38:05Z","timestamp":1528803485000},"page":"262-265","source":"Crossref","is-referenced-by-count":18,"title":["Human papillomavirus vaccine for children and adolescents"],"prefix":"10.1093","volume":"23","author":[{"given":"Marina I","family":"Salvadori","sequence":"first","affiliation":[{"name":"Canadian Paediatric Society, Infectious Diseases and Immunization Committee, Ottawa, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"key\n\t\t\t\t2018112111124859800_CIT0001","volume-title":"Update on Human Papillomavirus (HPV) Vaccines. Canada Communicable Disease Report","author":"Public Health Agency of Canada, National Advisory Committee on Immunization","year":"2012"},{"issue":"7","key":"key\n\t\t\t\t2018112111124859800_CIT0002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/pch\/12.7.599","article-title":"Human papillomavirus vaccine for children and adolescents","volume":"12","author":"Samson","year":"2007","journal-title":"Paediatr Child Health"},{"issue":"8","key":"key\n\t\t\t\t2018112111124859800_CIT0003","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: A systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112111124859800_CIT0004","volume-title":"Canadian Immunization Guide: Part 4 \u2013 Active Vaccines; Human Papillomavirus Vaccine","author":"Public Health Agency of Canada","year":"2017"},{"issue":"5","key":"key\n\t\t\t\t2018112111124859800_CIT0005","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/1097-0142(19930901)72:5<1666::AID-CNCR2820720528>3.0.CO;2-M","article-title":"Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner","volume":"72","author":"Agarwal","year":"1993","journal-title":"Cancer"},{"issue":"2","key":"key\n\t\t\t\t2018112111124859800_CIT0006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","article-title":"Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men","volume":"177","author":"Palefsky","year":"1998","journal-title":"J Infect Dis"},{"issue":"8","key":"key\n\t\t\t\t2018112111124859800_CIT0007","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpediatrics.2012.586","article-title":"Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose","volume":"166","author":"Widdice","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t2018112111124859800_CIT0008","volume-title":"Article: Trends in teen sexual behaviour and condom use. Health Reports","author":"Rotermann"},{"issue":"6","key":"key\n\t\t\t\t2018112111124859800_CIT0009","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/21645515.2016.1141158","article-title":"Tempest in a teapot: A systematic review of hpv vaccination and risk compensation research","volume":"12","author":"Kasting","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"17","key":"key\n\t\t\t\t2018112111124859800_CIT0010","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t2018112111124859800_CIT0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"key\n\t\t\t\t2018112111124859800_CIT0012","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017; Grading of scientific evidence (males)","volume":"92","author":"WHO","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"52","key":"key\n\t\t\t\t2018112111124859800_CIT0013","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/j.vaccine.2009.09.097","article-title":"Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far","volume":"27","author":"Agorastos","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"key\n\t\t\t\t2018112111124859800_CIT0014","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1503\/cmaj.080916","article-title":"Anaphylaxis following quadrivalent human papillomavirus vaccination","volume":"179","author":"Brotherton","year":"2008","journal-title":"CMAJ"},{"issue":"7","key":"key\n\t\t\t\t2018112111124859800_CIT0015","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"issue":"43","key":"key\n\t\t\t\t2018112111124859800_CIT0016","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2014.08.011","article-title":"Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults","volume":"32","author":"Giacomet","year":"2014","journal-title":"Vaccine"},{"issue":"17","key":"key\n\t\t\t\t2018112111124859800_CIT0017","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018112111124859800_CIT0018","volume-title":"Updated Recommendation on Human Papillomavirus (HPV) Vaccines: 9-valent HPV Vaccine 2-dose Immunization Schedule and the Use of HPV Vaccines in Immunocompromised Populations","author":"Public Health Agency of Canada, National Advisory Committee on Immunization"}],"container-title":["Paediatrics &amp; Child Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/pch\/article-pdf\/23\/4\/262\/26677062\/pxx179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T06:32:36Z","timestamp":1571466756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/23\/4\/262\/5036413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,6,12]]},"published-print":{"date-parts":[[2018,6,12]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxx179","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"value":"1205-7088","type":"print"},{"value":"1918-1485","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,6,12]]}}}